Valategrast
Alternative Names: R-411; Ro0272441/002; Ro27-2441; Ro27-2441/002Latest Information Update: 01 Apr 2008
At a glance
- Originator Roche
- Class Antiasthmatics
- Mechanism of Action Alpha4beta7 integrin antagonists; Integrin alpha4beta1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Multiple sclerosis
- Discontinued Asthma
Most Recent Events
- 19 Oct 2006 Discontinued - Phase-I for Asthma in USA (PO)
- 19 Oct 2006 Discontinued - Phase-II for Asthma in Europe (PO)
- 17 Oct 2006 Phase-I clinical trials in Multiple sclerosis in USA (PO)